Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
4.110
-0.030 (-0.72%)
At close: Jun 23, 2026, 4:00 PM EDT
4.098
-0.012 (-0.28%)
After-hours: Jun 23, 2026, 7:59 PM EDT
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $75.61 million as of June 23, 2026. Its market cap has decreased by -39.58% in one year.
Market Cap
75.61M
Enterprise Value
75.00M
1-Year Change
-39.58%
Ranking
Category
Stock Price
$4.11
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $75.61M, a decrease of -75.78%. That is a compound annual growth rate of -37.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 75.61M | -45.65% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MindWalk Holdings | 75.99M |
| Annovis Bio | 74.45M |
| Pliant Therapeutics | 71.83M |
| XBiotech | 70.43M |
| ImageneBio | 67.67M |
| Acrivon Therapeutics | 67.20M |
| KALA BIO | 67.11M |
| eXoZymes | 66.39M |